{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T03:43:21Z","timestamp":1775792601611,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T00:00:00Z","timestamp":1724630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.14283\/jpad.2024.156","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T05:50:40Z","timestamp":1724305840000},"page":"1634-1646","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Anti-Hypertensives Reduce the Rate of Alzheimer's Disease Progression: A Cohort Study Linked with Genetic and Neuropathological Analyses"],"prefix":"10.1016","volume":"11","author":[{"given":"Zohara","family":"Sternberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Podolsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Halvorsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Hojnacki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.J.","family":"Schaller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.14283\/jpad.2024.156_bib1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","article-title":"The global prevalence of dementia: a systematic review and metaanalysis","volume":"9","author":"Prince","year":"2013","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.14283\/jpad.2024.156_bib2","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer's disease: genes, proteins, and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiol Rev"},{"issue":"3","key":"10.14283\/jpad.2024.156_bib3","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.14283\/jpad.2024.156_bib4","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/brain\/awv029","article-title":"Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage","volume":"138","author":"Vos","year":"2015","journal-title":"Brain"},{"issue":"3","key":"10.14283\/jpad.2024.156_bib5","first-page":"93","article-title":"Mild cognitive impairment: transition between aging and Alzheimer's disease","volume":"15","author":"Petersen","year":"2000","journal-title":"Neurologia"},{"issue":"16","key":"10.14283\/jpad.2024.156_bib6","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1001\/jama.1995.03520400044042","article-title":"Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals","volume":"273","author":"Petersen","year":"1995","journal-title":"JAMA"},{"issue":"7","key":"10.14283\/jpad.2024.156_bib7","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1212\/WNL.52.7.1397","article-title":"Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment","volume":"52","author":"Jack","year":"1999","journal-title":"Neurology"},{"issue":"1","key":"10.14283\/jpad.2024.156_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/cns.12317","article-title":"Correlation of hippocampal volume and cognitive performances in patients with either mild cognitive impairment or Alzheimer's disease","volume":"21","author":"Peng","year":"2015","journal-title":"CNS Neurosci Ther"},{"issue":"3","key":"10.14283\/jpad.2024.156_bib9","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1447-0594.2012.00934.x","article-title":"Rate of progression of Alzheimer's disease in younger versus older patients: a longitudinal single photon emission computed tomography study","volume":"13","author":"Sakai","year":"2013","journal-title":"Geriatr Gerontol Int"},{"issue":"9","key":"10.14283\/jpad.2024.156_bib10","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.neurobiolaging.2008.08.018","article-title":"Whole brain atrophy rate predicts progression from MCI to Alzheimer's disease","volume":"31","author":"Spulber","year":"2010","journal-title":"Neurobiol Aging"},{"issue":"3","key":"10.14283\/jpad.2024.156_bib11","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2147\/NDT.S2154","article-title":"Strategies for molecular imaging dementia and neurodegenerative diseases","volume":"4","author":"Schaller","year":"2008","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"524","key":"10.14283\/jpad.2024.156_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau5732","article-title":"Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET","volume":"12","author":"La Joie","year":"2020","journal-title":"Sci Transl Med"},{"issue":"7","key":"10.14283\/jpad.2024.156_bib13","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/00325481.2019.1657776","article-title":"Alzheimer's dementia: pathogenesis and impact of cardiovascular risk factors on cognitive decline","volume":"131","author":"Wanleenuwat","year":"2019","journal-title":"Postgrad Med"},{"issue":"1","key":"10.14283\/jpad.2024.156_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/jgs.12067","article-title":"High blood pressure and cognitive decline in mild cognitive impairment","volume":"61","author":"Goldstein","year":"2013","journal-title":"J Am Geriatr Soc"},{"issue":"8","key":"10.14283\/jpad.2024.156_bib15","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.jalz.2016.03.012","article-title":"Life-course blood pressure in relation to brain volumes","volume":"12","author":"Power","year":"2016","journal-title":"Alzheimers Dement"},{"issue":"6","key":"10.14283\/jpad.2024.156_bib16","doi-asserted-by":"crossref","first-page":"e517","DOI":"10.1212\/WNL.0000000000005951","article-title":"Late-life blood pressure association with cerebrovascular and Alzheimer disease pathology","volume":"91","author":"Arvanitakis","year":"2018","journal-title":"Neurology"},{"issue":"4","key":"10.14283\/jpad.2024.156_bib17","doi-asserted-by":"crossref","first-page":"679","DOI":"10.14283\/jpad.2022.73","article-title":"Delayed Decline of Cognitive Function by Antihypertensive Agents: A Cohort Study Linked with Genotype Data","volume":"9","author":"Sternberg","year":"2022","journal-title":"J Prev Alzheimers Dis"},{"issue":"4","key":"10.14283\/jpad.2024.156_bib18","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s11065-018-9388-2","article-title":"Cognitive Deficits in Psychotic Disorders: A Lifespan Perspective","volume":"28","author":"Sheffield","year":"2018","journal-title":"Neuropsychol Rev"},{"issue":"1","key":"10.14283\/jpad.2024.156_bib19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13195-017-0237-y","article-title":"Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer's disease","volume":"9","author":"Geifman","year":"2017","journal-title":"Alzheimers Res Ther"},{"key":"10.14283\/jpad.2024.156_bib20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1472-6947-7-16","article-title":"Utilization of the PICO framework to improve searching PubMed for clinical questions","volume":"7","author":"Schardt","year":"2007","journal-title":"BMC Med Inform Decis Mak"},{"issue":"4","key":"10.14283\/jpad.2024.156_bib21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"issue":"11","key":"10.14283\/jpad.2024.156_bib22","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/JGP.0b013e318181276a","article-title":"Effects of cardiovascular medications on rate of functional decline in Alzheimer disease","volume":"16","author":"Rosenberg","year":"2008","journal-title":"Am J Geriatr Psychiatry"},{"issue":"3","key":"10.14283\/jpad.2024.156_bib23","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1093\/brain\/awac076","article-title":"Blood-brain barrier permeable beta-blockers linked to lower risk of Alzheimer's disease in hypertension","volume":"146","author":"Beaman","year":"2023","journal-title":"Brain"},{"issue":"6","key":"10.14283\/jpad.2024.156_bib24","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1097\/SLA.0000000000002286","article-title":"Beta-blockers and Traumatic Brain Injury: A Systematic Review, Meta-analysis, and Eastern Association for the Surgery of Trauma Guideline","volume":"266","author":"Alali","year":"2017","journal-title":"Ann Surg"},{"issue":"10","key":"10.14283\/jpad.2024.156_bib25","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1017\/S1461145713000631","article-title":"Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice","volume":"16","author":"Dobarro","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"issue":"6156","key":"10.14283\/jpad.2024.156_bib26","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.1241224","article-title":"Sleep drives metabolite clearance from the adult brain","volume":"342","author":"Xie","year":"2013","journal-title":"Science"},{"key":"10.14283\/jpad.2024.156_bib27","series-title":"Noradrenergic Signaling and Astroglia","first-page":"241","article-title":"Noradrenaline drives structural changes in astrocytes and brain extracellular space","author":"Sherpa","year":"2017"},{"issue":"4","key":"10.14283\/jpad.2024.156_bib28","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/HJH.0000000000000086","article-title":"Angiotension receptor blockers reduce the risk of dementia","volume":"32","author":"Chiu","year":"2014","journal-title":"J Hypertens"},{"key":"10.14283\/jpad.2024.156_bib29","doi-asserted-by":"crossref","first-page":"b5465","DOI":"10.1136\/bmj.b5465","article-title":"Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis","volume":"340","author":"Li","year":"2010","journal-title":"BMJ"},{"issue":"1","key":"10.14283\/jpad.2024.156_bib30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3233\/JAD-2009-0925","article-title":"Identification of antihypertensive drugs which inhibit amyloid-beta protein oligomerization","volume":"16","author":"Zhao","year":"2009","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"10.14283\/jpad.2024.156_bib31","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s11357-020-00231-y","article-title":"Brain angiotensin II and angiotensin IV receptors as potential Alzheimer's disease therapeutic targets","volume":"42","author":"Royea","year":"2020","journal-title":"Geroscience"},{"issue":"4","key":"10.14283\/jpad.2024.156_bib32","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1177\/2042098615589905","article-title":"Combination use of medicines from two classes of renin-angiotensin system blocking agents: risk of hyperkalemia, hypotension, and impaired renal function","volume":"6","author":"Esteras","year":"2015","journal-title":"Ther Adv Drug Saf"},{"issue":"10","key":"10.14283\/jpad.2024.156_bib33","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1161\/HYPERTENSIONAHA.122.19378","article-title":"Angiotensin Receptor Blockers Are Associated With a Lower Risk of Progression From Mild Cognitive Impairment to Dementia","volume":"79","author":"Deng","year":"2022","journal-title":"Hypertension"},{"key":"10.14283\/jpad.2024.156_bib34","doi-asserted-by":"crossref","first-page":"105515","DOI":"10.1016\/j.phrs.2021.105515","article-title":"Association between renin-angiotensin-aldosterone system inhibitors and risk of dementia: A meta-analysis","volume":"166","author":"Scotti","year":"2021","journal-title":"Pharmacol Res"},{"issue":"Suppl1","key":"10.14283\/jpad.2024.156_bib35","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.3317\/jraas.2002.029","article-title":"Organisation and functional role of the brain angiotensin system","volume":"3","author":"Llorens-Cortes","year":"2002","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"13","key":"10.14283\/jpad.2024.156_bib36","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1001\/archinternmed.2009.175","article-title":"Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study","volume":"169","author":"Sink","year":"2009","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.14283\/jpad.2024.156_bib37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13195-017-0255-9","article-title":"Alzheimer's Disease Neuroimaging I. Memory is preserved in older adults taking AT1 receptor blockers","volume":"9","author":"Ho","year":"2017","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"10.14283\/jpad.2024.156_bib38","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jagp.2012.08.017","article-title":"Angiotensin converting enzyme inhibitors and Alzheimer disease in the presence of the apolipoprotein E4 allele","volume":"22","author":"Qiu","year":"2014","journal-title":"Am J Geriatr Psychiatry"},{"issue":"6","key":"10.14283\/jpad.2024.156_bib39","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1152\/jappl.1994.76.6.2651","article-title":"Acute respiratory acidosis: large-dose furosemide and cerebrospinal fluid ions","volume":"76","author":"Javaheri","year":"1994","journal-title":"J Appl Physiol (1985)"},{"issue":"4","key":"10.14283\/jpad.2024.156_bib40","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.neurobiolaging.2012.09.010","article-title":"Prazosin, an alpha(1)-adrenoceptor antagonist, prevents memory deterioration in the APP23 transgenic mouse model of Alzheimer's disease","volume":"34","author":"Katsouri","year":"2013","journal-title":"Neurobiol Aging"},{"issue":"18","key":"10.14283\/jpad.2024.156_bib41","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1001\/archinte.162.18.2046","article-title":"The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study","volume":"162","author":"Forette","year":"2002","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.14283\/jpad.2024.156_bib42","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s11427-011-4205-7","article-title":"Early calcium dysregulation in Alzheimer's disease: setting the stage for synaptic dysfunction","volume":"54","author":"Chakroborty","year":"2011","journal-title":"Sci China Life Sci"},{"key":"10.14283\/jpad.2024.156_bib43","doi-asserted-by":"crossref","first-page":"101503","DOI":"10.1016\/j.arr.2021.101503","article-title":"Mitochondrial dysfunction, oxidative stress, neuroinflammation, and metabolic alterations in the progression of Alzheimer's disease: A meta-analysis of in vivo magnetic resonance spectroscopy studies","volume":"72","author":"Song","year":"2021","journal-title":"Ageing Res Rev"},{"issue":"12","key":"10.14283\/jpad.2024.156_bib44","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1001\/archneurol.2012.1010","article-title":"Impact of Angiotensin receptor blockers on Alzheimer disease neuropathology in a large brain autopsy series","volume":"69","author":"Hajjar","year":"2012","journal-title":"Arch Neurol"},{"issue":"5","key":"10.14283\/jpad.2024.156_bib45","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00401-017-1681-2","article-title":"Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART)","volume":"133","author":"Josephs","year":"2017","journal-title":"Acta Neuropathol"},{"issue":"6","key":"10.14283\/jpad.2024.156_bib46","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1001\/jamaneurol.2015.0202","article-title":"Cerebrospinal Fluid Markers of Neurodegeneration and Rates of Brain Atrophy in Early Alzheimer Disease","volume":"72","author":"Tarawneh","year":"2015","journal-title":"JAMA Neurol"},{"issue":"12","key":"10.14283\/jpad.2024.156_bib47","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1212\/WNL.0b013e3181b879ac","article-title":"Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer disease","volume":"73","author":"Henneman","year":"2009","journal-title":"Neurology"},{"issue":"48","key":"10.14283\/jpad.2024.156_bib48","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.1093\/eurheartj\/ehac584","article-title":"Blood pressure lowering and prevention of dementia: an individual patient data meta-analysis","volume":"43","author":"Peters","year":"2022","journal-title":"Eur Heart J"},{"issue":"1","key":"10.14283\/jpad.2024.156_bib49","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3233\/JAD-180583","article-title":"Positive Feedback Loops in Alzheimer's Disease: The Alzheimer's Feedback Hypothesis","volume":"66","author":"Doig","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"10.14283\/jpad.2024.156_bib50","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/EDE.0000000000000241","article-title":"Evaluating possible confounding by prescriber in comparative effectiveness research","volume":"26","author":"Franklin","year":"2015","journal-title":"Epidemiology"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724006940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724006940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T02:16:02Z","timestamp":1737339362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580724006940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2274580724006940"],"URL":"https:\/\/doi.org\/10.14283\/jpad.2024.156","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-Hypertensives Reduce the Rate of Alzheimer's Disease Progression: A Cohort Study Linked with Genetic and Neuropathological Analyses","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jpad.2024.156","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}